Latest Headlines

PR Newswire

GRIN Therapeutics Announces First Patient Dosed in Global Phase 3 Beeline Trial of Investigational Radiprodil for GRIN-Related Neurodevelopmental Disorder

PR Newswire

Magnet Defense Enters into Definitive Agreement to Acquire ATG to Accelerate Integration of AI-Enabled Autonomy Solutions for National Security